Clinical evaluation of the combined efficacy of injectable platelet-rich fibrin along with scaling and root planing in the non-surgical periodontal therapy of stage III and grade C periodontitis patients having type 2 diabetes mellitus: A randomized controlled trial
- PMID: 37749861
- DOI: 10.1002/cap.10266
Clinical evaluation of the combined efficacy of injectable platelet-rich fibrin along with scaling and root planing in the non-surgical periodontal therapy of stage III and grade C periodontitis patients having type 2 diabetes mellitus: A randomized controlled trial
Abstract
Background: This randomized controlled trial was aimed to evaluate the combined efficacy of injectable platelet-rich fibrin (i-PRF) and scaling and root planing (SRP) in type 2 diabetes mellitus subjects having periodontitis.
Methods: Twenty-six Stage III, grade C periodontitis subjects (HbA1c > 7) were recruited in this split-mouth study. Following SRP, the test sites received subgingival application of i-PRF, while the control sites received saline. Plaque index, bleeding on probing, modified gingival index, probing pocket depth (PPD) and clinical attachment level (CAL) were measured at baseline, 3 and 6 months.
Results: Twenty-three participants completed the course of research. The Friedman test followed by Dunn's post hoc test, revealed significant improvement in all the clinical parameters from baseline to 3 and 6 months in both the study groups (p ≤ 0.05). The mean PPD and CAL decreased from 6.30 ± 1.25 and 7.48 ± 1.75 at baseline to 3.48 ± 1.34 and 4.39 ± 1.67 at 6 months in control sites and from 6.57 ± 1.56 and 7.61 ± 1.69 to 3.39 ± 1.23 and 4.26 ± 1.81 at 6 months in test sites (p ≤ 0.0001). Intergroup analysis found no statistical significant differences in the evaluated parameters across all time intervals (p > 0.05) CONCLUSION: The results indicated that the adjunctive application of i-PRF to SRP provided similar benefits as saline and SRP in diabetes mellitus subjects.
Key points: Question: To find the combined efficacy of injectable platelet-rich fibrin (i-PRF) along with scaling and root planing (SRP) in the management of periodontal pockets of Stage III and Grade C periodontitis patients having Type 2 Diabetes Mellitus (T2DM).
Finding: All of the treated sites showed satisfactory healing. Both the treatment modalities (i-PRF + SRP and Saline + SRP) were effective in the treatment of periodontal pockets. At 3 and 6 months, there were no significant differences in periodontal parameters between groups. Meaning: The application of i-PRF as an adjunct to SRP provided similar benefits as saline and SRP in improving clinical parameters in subjects with stage III and grade C periodontitis patients having T2DM (HbA1C > 7).
Keywords: diabetes mellitus; periodontal pocket; periodontitis; platelet‐rich fibrin; root planing.
© 2023 American Academy of Periodontology.
Similar articles
-
Platelet-Rich Plasma (PRP) and Injectable Platelet-Rich Fibrin (i-PRF) in the Non-Surgical Treatment of Periodontitis-A Systematic Review.Int J Mol Sci. 2024 Jun 7;25(12):6319. doi: 10.3390/ijms25126319. Int J Mol Sci. 2024. PMID: 38928026 Free PMC article.
-
The clinical efficacy of injectable platelet-rich fibrin (i-PRF) as an adjunct to nonsurgical periodontal therapy in smokers with periodontitis.BMC Oral Health. 2025 Apr 23;25(1):618. doi: 10.1186/s12903-025-06019-w. BMC Oral Health. 2025. PMID: 40269777 Free PMC article. Clinical Trial.
-
Adjuvant effects of injectable platelet-rich fibrin (i-PRF) in the non-surgical periodontal therapy: a split-mouth randomized controlled clinical trial.Clin Oral Investig. 2025 Jun 16;29(7):341. doi: 10.1007/s00784-025-06423-0. Clin Oral Investig. 2025. PMID: 40522340 Clinical Trial.
-
Clinical effectiveness of a topical subgingival application of injectable platelet-rich fibrin as adjunctive therapy to scaling and root planing: a double-blind, split-mouth, randomized, prospective, comparative controlled trial.Quintessence Int. 2021 Jul 20;52(8):676-685. doi: 10.3290/j.qi.b1492019. Quintessence Int. 2021. PMID: 34076375 Clinical Trial.
-
Effect of non-surgical periodontal therapy on glycemic control of type 2 diabetes mellitus: a systematic review and Bayesian network meta-analysis.BMC Oral Health. 2019 Aug 6;19(1):176. doi: 10.1186/s12903-019-0829-y. BMC Oral Health. 2019. PMID: 31387569 Free PMC article.
Cited by
-
Levels of peripheral CD4 + and CD8 + T cells and glycaemic control level in patients with both type 2 mellitus diabetes and stage III-IV periodontitis: a randomized controlled trial in Chinese population.BMC Oral Health. 2025 Jul 2;25(1):1065. doi: 10.1186/s12903-025-06462-9. BMC Oral Health. 2025. PMID: 40604671 Free PMC article. Clinical Trial.
-
Efficacy of injectable platelet-rich fibrin (i-PRF) as a novel vehicle for local drug delivery in non-surgical periodontal pocket therapy: A randomized controlled clinical trial.J Adv Periodontol Implant Dent. 2024 Sep 11;16(2):94-102. doi: 10.34172/japid.2024.021. eCollection 2024. J Adv Periodontol Implant Dent. 2024. PMID: 39758269 Free PMC article.
-
Platelet-Rich Plasma (PRP) and Injectable Platelet-Rich Fibrin (i-PRF) in the Non-Surgical Treatment of Periodontitis-A Systematic Review.Int J Mol Sci. 2024 Jun 7;25(12):6319. doi: 10.3390/ijms25126319. Int J Mol Sci. 2024. PMID: 38928026 Free PMC article.
-
Autologous platelet concentrates as adjuncts to non-surgical periodontal therapy: a systematic review and meta-analysis.Clin Oral Investig. 2025 Jan 22;29(1):74. doi: 10.1007/s00784-024-06128-w. Clin Oral Investig. 2025. PMID: 39841297 Free PMC article.
-
The clinical efficacy of injectable platelet-rich fibrin (i-PRF) as an adjunct to nonsurgical periodontal therapy in smokers with periodontitis.BMC Oral Health. 2025 Apr 23;25(1):618. doi: 10.1186/s12903-025-06019-w. BMC Oral Health. 2025. PMID: 40269777 Free PMC article. Clinical Trial.
References
REFERENCES
-
- Könönen E, Gursoy M, Gursoy UK. Periodontitis: a multifaceted disease of tooth‐supporting tissues. J Clin Med. 2019;8(8):1135. 10.3390/jcm8081135.
-
- Graves DT, Ding Z, Yang Y. The impact of diabetes on periodontal diseases. Periodontol 2000. 2020;82(1):214‐224. 10.1111/prd.12318
-
- Baeza M, Morales A, Cisterna C, et al. Effect of periodontal treatment in patients with periodontitis and diabetes: systematic review and meta‐analysis. J Appl Oral Sci. 2020;28:e20190248. 10.1590/1678‐7757‐2019‐0248.
-
- Retamal I, Hernández R, Velarde V, et al. Diabetes alters the involvement of myofibroblasts during periodontal wound healing. Oral Dis. 2020;26(5):1062‐1071. 10.1111/odi.13325
-
- Hsu YT, Nair M, Angelov N, Lalla E, Lee CT. Impact of diabetes on clinical periodontal outcomes following non‐surgical periodontal therapy. J Clin Periodontol. 2019;46(2):206‐217. 10.1111/jcpe.13044
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical